Drug induced complications; can we do more?

J Cyst Fibros. 2013 Dec;12(6):547-58. doi: 10.1016/j.jcf.2013.04.014. Epub 2013 Jun 13.

Abstract

Drug induced complication are becoming increasingly common in CF. In this review we discuss some of the key issues relating to drug side in an ageing population of patients with CF. Strategies to reduce drug complications are also discussed.

Publication types

  • Review

MeSH terms

  • Administration, Inhalation
  • Adrenal Cortex Hormones / administration & dosage
  • Adrenal Cortex Hormones / adverse effects
  • Aminoglycosides / administration & dosage
  • Aminoglycosides / adverse effects
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / adverse effects
  • Comorbidity
  • Coronary Disease / epidemiology
  • Cystic Fibrosis / complications
  • Cystic Fibrosis / drug therapy*
  • Cystic Fibrosis / epidemiology
  • Cystic Fibrosis / microbiology
  • Diabetes Complications / drug therapy
  • Diabetes Mellitus / epidemiology
  • Disease Progression
  • Drug Hypersensitivity / etiology
  • Exocrine Pancreatic Insufficiency / drug therapy
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Intestines / microbiology
  • Magnetic Resonance Imaging
  • Microbiota / drug effects
  • Patient Compliance
  • Piperacillin / administration & dosage
  • Piperacillin / adverse effects

Substances

  • Adrenal Cortex Hormones
  • Aminoglycosides
  • Anti-Bacterial Agents
  • Hypoglycemic Agents
  • Piperacillin